Gba2 - glucosylceramidase beta 2 Gene
Species: Rattus norvegicus
Summary
Predicted to enable glucosylceramidase activity; glucosyltransferase activity; and steryl-beta-glucosidase activity. Predicted to be involved in several processes, including glucosylceramide catabolic process; lipid glycosylation; and regulation of protein polymerization. Predicted to be located in cytosol. Predicted to be extrinsic component of Golgi membrane; extrinsic component of endoplasmic reticulum membrane; and integral component of membrane. Human ortholog(s) of this gene implicated in hereditary spastic paraplegia 46. Orthologous to human GBA2 (glucosylceramidase beta 2). [provided by Alliance of Genome Resources, Apr 2022]
Gba2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001013091.2 | NP_001013109.2 | non-lysosomal glucosylceramidase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
non-lysosomal glucosylceramidase |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-129411 | Sinbaglustat | 99.83% | Unkown | |
| HY-178202 | 5-C-phenethyl-DNJ | Inhibitor | / | Unkown |
| HY-RS05302 | GBA2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18361 | Gba2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24840 | Gba2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service